Search results
Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
Morningstar· 2 days agoDesigned with the application of Ensysce's TAAP platform to reduce the abuse profile, lead candidate PF9001 has shown lower potential for cardiovascular side effects associated ...
Expert: If You're a Senior, Watch Out for These 7 Common Mental Health Issues
Cheapism via AOL· 2 days agoAn estimated 2.5 million Americans 65 and older have a substanceabuse problem, according to the ...
Minnesota Will Allow Oral Fluid Testing For Drugs, Cannabis and Alcohol | JD Supra
JD Supra· 4 days agoMinnesota will amend its drug testing law to permit oral fluid testing for drugs, cannabis and alcohol, effective August 1, 2024. The Drug and Alcohol Testing ...
Workplace Policies Begin to Evolve After Ohio Legalizes Cannabis Use
Cleveland Scene· 18 hours agoThough it is now legal for Ohioans to use cannabis, the 2023 passage of Issue 2 does not prevent...
Psychoactive drugs are having a moment. The FDA will soon weigh in
The State· 5 days agoPsychoactive drugs are having a moment. Investors are piling into the nascent field, and a host of medications based on MDMA, LSD, psychedelic mushrooms, ketamine, the South ...
McDermottPlus Check-Up: June 7, 2024
The National Law Review· 15 hours agoThe hearing aimed to gather more information on the response to the COVID-19 pandemic by Anthony Fauci, MD, former National Institute ...
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
seattlepi.com· 3 days agoA first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was...
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
The Nashua Telegraph· 2 days agoFederal health advisers are considering the first request to approve the mind-altering club drug...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
Courthouse News Service· 4 days agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
FDA panel rejects psychedelic drug MDMA as a PTSD treatment - Maryland Daily Record
The Daily Record· 3 days agoA panel of advisers to the Food and Drug Administration voted 10-1 against the overall benefits of...